Biomarkers of brain inflammation could provide a useful means for classifying Parkinson’s and Alzheimer’s patients and defining the…
Articles by Ana Pena, PhD
The first patient has been dosed in a Phase 2 study testing NLY01, an investigational compound with a…
Dizziness — including sensations of fainting, imbalance, and vertigo — is common among Parkinson’s patients and may be a potential…
Together with dying nerve cells, dormant neurons also may be at the root cause of Parkinson’s disease, according…
A saliva test may help diagnose Parkinson’s and assess disease severity, according to a recent study. Biomarkers…
Not everyone’s brain connections map at exactly the same location, which may explain why deep brain stimulation (DBS) therapy, used…
Brain magnetic resonance imaging (MRI) scans could be used to detect early and subtle markers of cognitive impairment…
Researchers have found new gene networks associated with the development of Parkinson’s disease, which may help them understand the…
Earlier onset of disease, early impairment of memory and thinking, and higher daily use of antiparkinson medication, are associated with…
Researchers have discovered a new enzyme that might aid in “putting the brakes” on Parkinson’s by inhibiting the LRRK2…